Board approves Rs. 138.99 crore preferential issue of 9,12,759 shares to 15 non-promoter investors
The Board has approved issuing up to 9,12,759 equity shares of face value Rs. 10/- each by preferential allotment at Rs. 1522.85 per share, totalling Rs. 138,99,95,043.15/- in cash.
- Issue Size
- Rs. 138,99,95,043.15/-
- Number of Shares
- 9,12,759 equity shares
- Issue Price per Share
- Rs. 1522.85
- Post-issue Shareholding
- 15 investors would hold 9,45,483 shares or 12.11%
- EGM Date
- October 23, 2026 at 11:30 A.M via video conferencing
What the Board approved
The Board of Bharat Parenterals Limited approved the issuance of up to 9,12,759 equity shares of face value Rs. 10/- each, fully paid up, through preferential allotment for cash.
- Issue price: Rs. 1522.85 per equity share
- Aggregate consideration: Rs. 138,99,95,043.15/-
- Allottees: 15 (Fifteen) investors, all non-promoters
- Subject to shareholder approval and other regulatory/statutory approvals
Who is coming in
The proposed allottees include alternative investment funds, foreign portfolio investors, mutual funds, an LLP and individuals. The largest proposed allotments are:
- WhiteOak Capital India Opportunities Fund (AIF): 3,02,065 shares, 3.87% post-issue
- Aurum Rising India Fund (AIF): 1,64,165 shares, 2.10% post-issue
- WhiteOak Capital Equity Fund II (AIF): 1,31,332 shares, 1.68% post-issue
- Ashok India Equity Investment Trust PLC (FPI): 80,631 shares, 1.03% post-issue
- WhiteOak Capital Multi Cap Fund (Mutual Fund): 45,966 shares, 0.59% post-issue
Taken together, these 15 investors hold 32,724 shares (0.472%) before the issue and would hold 9,45,483 shares (12.11%) after it.
Other Board decisions
The Board also approved undertaking investments in, or providing loans to, the subsidiaries of the Company for development of existing and new projects, in the form of equity, quasi equity or unsecured loan.
Next step
An Extraordinary General Meeting has been convened for Friday, October 23, 2026 at 11:30 A.M through video conferencing or other audio-visual means, to seek shareholder approval for the preferential issue. The Board meeting ran from 03:00 P.M. to 04:00 P.M.
How to read this
A preferential allotment brings fresh cash into the company from named investors rather than from the open market. Existing shareholders' stakes get diluted as new shares are created, since the new investors would account for 12.11% of the enlarged capital. The profile of the incoming investors — institutional funds and FPIs — is what readers often look at alongside the issue price.
Also from Bharat Parenterals
EGM on October 23, 2026 to consider preferential issue of 9,12,759 shares and higher Section 186 limits
1 Oct 2026
Board Meeting on 29 September 2026 to Consider Fund Raising via Preferential Issue
24 Sep 2026
More numbers
- Equity shares proposed to be issued9,12,759
- Face value per shareRs. 10/-
- Issue price per equity shareRs. 1522.85
- Aggregate considerationRs. 138,99,95,043.15/-
- Number of investors15 (Fifteen)
- WhiteOak Capital India Opportunities Fund allotment3,02,065
- WhiteOak Capital India Opportunities Fund post-issue stake3.87
- Aurum Rising India Fund allotment1,64,165
- Aurum Rising India Fund post-issue stake2.10
- Total pre-issue shareholding of allottees32,724
- Total post-issue shareholding of allottees9,45,483
- Total post-issue stake of allottees12.11
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.